Richard LeBlanc

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Newly Diagnosed

Multiple Myeloma

Acute Lymphoblastic Leukemia

Peritoneal Dialysis

Top Venues

Current oncology (Toronto, Ont.)

European journal of haematology

Clinical transplantation

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Richard LeBlanc, Hira S Mian, Donna Reece, Jiandong Su, Esther Masih-Khan, Michael Chu, Victor H Jimenez-Zepeda, Michael Sebag, Kevin Song, Martha Louzada, Rami Kotb, Alissa Visram, Darrell White, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Debra Bergstrom, Rayan Kaedbey, Engin Gul, Christopher P Venner
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis. European journal of haematology (2023)
Arleigh McCurdy, Christopher P Venner, Esther Masih-Khan, Martha Louzada, Richard LeBlanc, Michael Sebag, Kevin Song, Victor H Jimenez-Zepeda, Rami Kotb, Moustafa Kardjadj, Hira Mian, Darrell White, Julie Stakiw, Muhammad Aslam, Anthony Reiman, Engin Gul, Donna Reece
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database. Current oncology (Toronto, Ont.) 29 (3) (2022)
Richard LeBlanc, Imran Ahmad, Rafik Terra, Jean-Samuel Boudreault, David Ogez, Kristopher Lamore, Jean-Sébastien Delisle, Nadia Bambace, Léa Bernard, Sandra Cohen, Thomas Kiss, Sylvie Lachance, Séverine Landais, Émilie Lemieux-Blanchard, Guy Sauvageau, Michael Sebag, Denis Claude Roy, Jean Roy
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study. Bone marrow transplantation (2021)
Richard LeBlanc, Jean-Sébastien Claveau, Imran Ahmad, Jean-Sébastien Delisle, Nadia Bambace, Léa Bernard, Sandra Cohen, Thomas Kiss, Silvy Lachance, Séverine Landais, Denis Claude Roy, Guy Sauvageau, Jean Roy
Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only. Clinical transplantation 34 (12) (2020)